Form 4: Director John A. Roush Reports Changes in Beneficial Ownership of LeMaitre Vascular Inc (LMAT)

Director John A. Roush reports the acquisition of dividend equivalent rights related to restricted stock units and performance share units of LeMaitre Vascular Inc.

Summary

• On March 27, 2025, John A. Roush, a director of LeMaitre Vascular Inc (LMAT), reported the acquisition of dividend equivalent rights.
• These rights are associated with restricted stock unit (RSU) and performance share unit (PSU) awards previously granted to Roush.
• The dividend equivalent rights vest proportionately with the underlying RSU and PSU awards.
• The reported transactions involve dividend equivalent rights accrued on awards granted on December 12, 2022, December 8, 2023, and December 6, 2024.
• The total dividend equivalent rights acquired are 0.4803, 0.4803, 0.8214, 0.9838, and 1.001, corresponding to the respective grants.
• Each dividend equivalent right represents the economic equivalent of one share of LeMaitre Vascular's common stock.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing related to director compensation, and does not contain information that would significantly impact investor sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the director's continued holding of equity-based compensation.

Key Dates

Keywords

dividend equivalent rights, Form 4, LMAT, LeMaitre Vascular, Roush, director, beneficial ownership, restricted stock units, performance share units